Netherlands· NL-8e642e507127

Lamotrigine Desitin 20 mg/ml suspensie voor oraal gebruik

A lamotrigine product containing lamotrigine, registered in Netherlands by Desitin Arzneimittel GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lamotrigineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lamotrigine is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search lamotrigine products by name

Lamotrigine · ATC N03AX09

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lamotrigine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Lamotrigine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$4.21
IT Italy$2.00
FR France$1.69
US United States$0.14 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LAMOTRIGINE
Manufacturer: Desitin Arzneimittel GmbH
Country: Netherlands (NL)
ATC code: N03AX09
ATC class: Lamotrigine
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132228

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for lamotrigine.

Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lamotrigine against other medicines How interaction checks work

Lamotrigine · interactions on record

248 records

68 moderate
9 minor
129 info

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate
NabiloneA04AD11moderate

42 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lamotrigine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamotrigine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Gerolamic, Lamictal
Belgium · Lambipol, Lamictal
Bulgaria · Епитрижин, Ламиктал
Cyprus · Lamictal, Lamosynt
Czechia · Lamictal, Lamotrigin Actavis
Germany · Lamictal, Lamotrigin 1 A Pharma
Denmark · Lamictal, Lamotrigin
Estonia · Lamictal, Lamotrigine Desitin
Spain · Crisomet, Labileno
Finland · Lamictal, Lamotrigin Desitin
France · Lamictal, Lamotrigine
United Kingdom (Northern Ireland) · Lamictal, Lamotrigine
Greece · Dezepil, Lamictal
Croatia · Arvind, Lamal
Hungary · Gerolamic, Lamictal
Ireland · Lamictal, Lamotrigine Desitin
Iceland · Lamictal
Italy · Amaless, Lamictal
Lithuania · Lamictal
Luxembourg · Lambipol, Lamictal
Latvia · Lamictal, Lamotrix
Malta · Lamictal, Lamotrigine Aurobindo
Norway · Lamictal, Lamotrigin Desitin
Poland · Epitrigine, Lamilept
Portugal · Lamictal, Lamotrigina Accord
Romania · Lamictal, Lamotrix
Sweden · Lamictal, Lamotrigin
Slovenia · Lamal, Lamictal
Slovakia · Lamictal, Lamotrigin Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bf3fd17f-dfa2-4553-a63d-b9cac81f7806
GET /v1/drugs/bf3fd17f-dfa2-4553-a63d-b9cac81f7806?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132228_smpc.pdf",
  "strength": null,
  "atc_label": "Lamotrigine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132228",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "BENZOËZUUR (E 210)",
    "CARBOMEER 974P",
    "GLYCEROL (E 422)",
    "GLYCEROLMONOSTEARAAT (E 471)",
    "MACROGOLSTEARAAT",
    "METHYLCELLULOSE (E 461)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 65 (E 436)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "SIMETICON",
    "SIMETICON EMULSIE",
    "SORBINEZUUR (E 200)",
    "WATER, GEZUIVERD",
    "WATER, GEZUIVERD",
    "XANTHAANGOM (E 415)",
    "ZWAVELZUUR (E 513)"
  ],
  "substances": [
    "LAMOTRIGINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132228.pdf",
  "authorised_at": "2026/01/12",
  "procedure_number": "DE/H/7905/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132228",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about lamotrigine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console